Mirador Therapeutics, Inc.

This study aims to test the safety and effectiveness of several new experimental drugs for adults with moderate-to-severe Crohn's disease or ulcerative colitis. It will enroll 140 participants to see if these treatments can reduce gut inflammation and control symptoms. The trial …

This is the first study testing a new biologic therapy called MT-701 in humans. Researchers want to understand if it's safe and how the body processes it in 78 healthy volunteers. The study will check for side effects and how the drug moves through the body to decide if further t…

This is the very first study in people for a new drug called MT-251. Its main goal is to check if the drug is safe and how the body processes it in 70 healthy volunteers. Researchers will give participants either the drug or a placebo and closely monitor them. The results will he…

This is the first study testing the experimental drug MT-201 in humans. Researchers will give single and multiple doses to 72 healthy volunteers to check for side effects and see how the body processes the drug. The main goal is to determine if MT-201 is safe enough for further t…